Episodes (Page 20)
✨
Beverley Law discusses creative innovation in consumer health.
Beverley Law
✨
RFK Jr.'s commitments to secure HHS nomination discussed.
✨
Biopharma VC fundraising shows recovery; Daiichi Sankyo's outlook.
✨
Harness Therapeutics CEO discusses scientific strategy.
Harness Therapeutics CEO
✨
Trump administration's policies begin altering the US FDA.
✨
Epidemiologists discuss AI and real-world data at ISPOR.
Lucia Rodriguez-Garcia
Ridwaan Ibrahim
✨
Biopharma news: Medicare price negotiations for semaglutide.
✨
Questions arise as Trump administration takes control of US FDA.
✨
Biopharma news: JPM insights, J&J's Intra-Cellular buy.
✨
Fauna Bio uses AI to find drug targets from animal resistance.
Ashley Zender
✨
Advice for Trump administration on implementing FDA reforms.
Patrizia Cavazzoni
✨
Faron Pharma CEO discusses unmet needs in cancer treatment.
✨
Key themes for JPM conference discussed.
Drug Fix: CDER Director Retires, US FDA Guidance ‘Blizzard,’ Rare Pediatric Disease Program Hangs On
✨
CDER Director Patrizia Cavazzoni's retirement announcement.
Patrizia Cavazzoni
✨
Key themes for the 2025 JPM Healthcare Conference.
✨
Biotech executives discuss 2025 dealmaking challenges and opportunities.
✨
AI/GenAI adoption expected to increase in medtech.
Brian Bossetta
Elizabeth Orr
Marion Webb
Natasha Barrow
✨
Harnessing the innate immune system with dendritic cells.
Brian Bossetta
Elizabeth Orr
Jonathan Kagan
Natasha Barrow
✨
Discussion on the non-alcoholic steatohepatitis (NASH) treatment market.
Ken Hoang
✨
Top 5 global biopharma news selected by Scrip for 2024.